136 related articles for article (PubMed ID: 22968517)
21. LyGDI is a promising biomarker for ovarian cancer.
Zhen H; Yang S; Wu H; Wang S; Lv J; Ma L; Zhang X
Int J Gynecol Cancer; 2010 Apr; 20(3):316-22. PubMed ID: 20375790
[TBL] [Abstract][Full Text] [Related]
22. Concurrent endometrial intraepithelial carcinoma (EIC) and serous ovarian cancer: can EIC be seen as the precursor lesion?
Roelofsen T; van Kempen LC; van der Laak JA; van Ham MA; Bulten J; Massuger LF
Int J Gynecol Cancer; 2012 Mar; 22(3):457-64. PubMed ID: 22249577
[TBL] [Abstract][Full Text] [Related]
23. Characteristics and prognosis of coexisting adnexa malignancy with endometrial cancer: a single institution review of 51 cases.
Chen L; Zhao Q; Lv X
Arch Gynecol Obstet; 2011 May; 283(5):1133-7. PubMed ID: 20585952
[TBL] [Abstract][Full Text] [Related]
24. Synchronous primary malignancies of the female genital tract.
Ayhan A; Yalçin OT; Tuncer ZS; Gürgan T; Küçükali T
Eur J Obstet Gynecol Reprod Biol; 1992 Jun; 45(1):63-6. PubMed ID: 1618363
[TBL] [Abstract][Full Text] [Related]
25. Comparison and analysis of the clinicopathological features of SCEO and ECOM.
Wang T; Zhang X; Lu Z; Wang J; Hua K
J Ovarian Res; 2019 Jan; 12(1):10. PubMed ID: 30700327
[TBL] [Abstract][Full Text] [Related]
26. Synchronous primary carcinomas of the endometrium and ovary.
Sheu BC; Lin HH; Chen CK; Chao KH; Shun CT; Huang SC
Int J Gynaecol Obstet; 1995 Nov; 51(2):141-6. PubMed ID: 8635635
[TBL] [Abstract][Full Text] [Related]
27. Combination of Scoring Criteria and Whole Exome Sequencing Analysis of Synchronous Endometrial and Ovarian Carcinomas.
Yang L; Zhang L; Huang Q; Liu C; Qi L; Li L; Qu T; Wang Y; Liu S; Meng B; Sun B; Cao W
Int J Gynecol Cancer; 2018 May; 28(4):704-712. PubMed ID: 29498984
[TBL] [Abstract][Full Text] [Related]
28. Clinicopathologic analysis of women with synchronous primary carcinomas of the endometrium and ovary: 10- year experience from Chiang Mai University Hospital.
Natee J; Kietpeerakool C; Srisomboon J; Khunamornpong S; Suprasert P; Phongnarisorn C; Cheewakriangkrai C; Charoenkwan K; Siriaree S; Pantusart A
Asian Pac J Cancer Prev; 2006; 7(2):234-8. PubMed ID: 16839215
[TBL] [Abstract][Full Text] [Related]
29. Synchronous primary endometrial and ovarian cancer with three different histologic patterns: A case report.
Ree YS; Cho SH; Kim SR; Cho SH; Kim KT; Park MH
Int J Gynecol Cancer; 2003; 13(5):678-82. PubMed ID: 14675354
[TBL] [Abstract][Full Text] [Related]
30. Are surveillance procedures of clinical benefit for patients treated for ovarian cancer?: A retrospective Italian multicentric study.
Gadducci A; Fuso L; Cosio S; Landoni F; Maggino T; Perotto S; Sartori E; Testa A; Galletto L; Zola P
Int J Gynecol Cancer; 2009 Apr; 19(3):367-74. PubMed ID: 19407561
[TBL] [Abstract][Full Text] [Related]
31. Synchronous early-stage endometrial and ovarian cancer.
Signorelli M; Fruscio R; Lissoni AA; Pirovano C; Perego P; Mangioni C
Int J Gynaecol Obstet; 2008 Jul; 102(1):34-8. PubMed ID: 18342863
[TBL] [Abstract][Full Text] [Related]
32. Clinicopathologic analysis with immunohistochemistry for DNA mismatch repair protein expression in synchronous primary endometrial and ovarian cancers.
Kobayashi Y; Nakamura K; Nomura H; Banno K; Irie H; Adachi M; Iida M; Umene K; Nogami Y; Masuda K; Kisu I; Ueki A; Yamagami W; Kataoka F; Hirasawa A; Tominaga E; Susumu N; Aoki D
Int J Gynecol Cancer; 2015 Mar; 25(3):440-6. PubMed ID: 25695547
[TBL] [Abstract][Full Text] [Related]
33. Molecular profiling identifies synchronous endometrial and ovarian cancers as metastatic endometrial cancer with favorable clinical outcome.
Reijnen C; Küsters-Vandevelde HVN; Ligtenberg MJL; Bulten J; Oosterwegel M; Snijders MPLM; Sweegers S; de Hullu JA; Vos MC; van der Wurff AAM; van Altena AM; Eijkelenboom A; Pijnenborg JMA
Int J Cancer; 2020 Jul; 147(2):478-489. PubMed ID: 32022266
[TBL] [Abstract][Full Text] [Related]
34. Application of clonal analysis. Differential diagnosis for synchronous primary ovarian and endometrial cancers and metastatic cancer.
Fujita M; Enomoto T; Wada H; Inoue M; Okudaira Y; Shroyer KR
Am J Clin Pathol; 1996 Mar; 105(3):350-9. PubMed ID: 8602617
[TBL] [Abstract][Full Text] [Related]
35. The risk of malignancy index (RMI) in diagnosis of ovarian malignancy.
Moolthiya W; Yuenyao P
Asian Pac J Cancer Prev; 2009; 10(5):865-8. PubMed ID: 20162854
[TBL] [Abstract][Full Text] [Related]
36. Should All Cases of High-Grade Serous Ovarian, Tubal, and Primary Peritoneal Carcinomas Be Reclassified as Tubo-Ovarian Serous Carcinoma?
Moss EL; Evans T; Pearmain P; Askew S; Singh K; Chan KK; Ganesan R; Hirschowitz L
Int J Gynecol Cancer; 2015 Sep; 25(7):1201-7. PubMed ID: 26035124
[TBL] [Abstract][Full Text] [Related]
37. Assessment of the clinicopathological relevance of mesothelin level in plasma, peritoneal fluid, and tumor tissue of epithelial ovarian cancer patients.
Okła K; Surówka J; Frąszczak K; Czerwonka A; Kaławaj K; Wawruszak A; Kotarski J; Wertel I
Tumour Biol; 2018 Oct; 40(10):1010428318804937. PubMed ID: 30319054
[TBL] [Abstract][Full Text] [Related]
38. Synchronous primary endometrial and ovarian cancers: a multicenter review of 63 cases.
Solmaz U; Karatasli V; Mat E; Dereli L; Hasdemir PS; Ekin A; Gezer C; Sayhan S; Sanci M; Guvenal T
Tumori; 2016 Oct; 102(5):508-513. PubMed ID: 26166222
[TBL] [Abstract][Full Text] [Related]
39. Clinical significance of galectin-7 in epithelial ovarian cancer.
Kim HJ; Jeon HK; Lee JK; Sung CO; Do IG; Choi CH; Kim TJ; Kim BG; Bae DS; Lee JW
Anticancer Res; 2013 Apr; 33(4):1555-61. PubMed ID: 23564797
[TBL] [Abstract][Full Text] [Related]
40. Synchronous primary endometrial and ovarian cancers: a case report.
Decavalas G; Adonakis G; Androutsopoulos G; Gkogkos P; Koumoundourou D; Ravazoula P; Kourounis G
Eur J Gynaecol Oncol; 2006; 27(4):434-6. PubMed ID: 17009647
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
